Generic Injectables: Pharma Takes A Shot At A Growing Market
Executive Summary
When it comes to drugs driving generic growth, usually blockbusters such as Lipitor and Plavix come to mind. But there is another area of the generic market that offers plenty of dynamic potential - sterile drugs administered by injection or infusion
You may also be interested in...
Sagent Turns Generic Injectable Shortages Into Business Opportunity
The specialty generic manufacturer has a facility dedicated to producing shortage drugs, a seemingly endless commercial opportunity given the development, regulatory and reimbursement challenges in the sterile injectable space.
Sagent Turns Generic Injectable Shortages Into Business Opportunity
The specialty generic manufacturer has a facility dedicated to producing shortage drugs, a seemingly endless commercial opportunity given the development, regulatory and reimbursement challenges in the sterile injectable space.
Managing The World’s First Blockbuster Generic: An Interview With Sandoz’s George
Jeff George, global head of Sandoz, talks about enoxaparin, a commitment to quality manufacturing, and investing in differentiated products.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: